Yurovskikh NV, Jarygina GV. Clinical experience with idarucizumab prior to thrombolytic therapy of cerebral infarction in the Sverdlovsk region. Ural Medical Journal. 2021;20(4):73-77. (In Russ.) https://doi.org/10.52420/2071-5943-2021-20-4-73-77
Email this article (Login required)
Email the author (Login required) Ural Medical Journal
Founder and Publisher: Ural State Medical University, 3, Repina Street, Ekaterinburg, 620028, Russia
Editorial Office Address: 3, Repina Street, Ekaterinburg, 620028, Russia
Editor-in-Chief: Olga P. Kovtun
E-mail: umjusmu@yandex.ru
The Journal is registered by the Federal Service for Supervision of Communications, Information Technology, and Mass Media. Mass Media Registration Certificate: EL No. FS 77 - 87080 dated 22 April 2024
The Journal is not marked with the Sign of Information Products in accordance with Paragraph 2 of Article 1 of the Federal Law of the Russian Federation No. 436-FL of December 29, 2010 as containing scientific information
© Ural State Medical University
Processing of personal data
